Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)

Esophageal cancer (EC) is particularly common in China. With the continuing progress of multi-disciplinary therapy including early screening, minimally invasive techniques, radiotherapy and chemotherapy, the 5-year survival of EC has been improved in China. However, there are considerable disparitie...

Full description

Bibliographic Details
Main Authors: Ruixiang Zhang, Zhen Wang, Xiaozheng Kang, Xin Wang, Bo Zhang, Hoi-loi Ng, Liyan Xue, Wenjing Yang, Liming Shi, Hui Wang, Lvhua Wang, Yin Li
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Journal of the National Cancer Center
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667005423000455
_version_ 1797672030033674240
author Ruixiang Zhang
Zhen Wang
Xiaozheng Kang
Xin Wang
Bo Zhang
Hoi-loi Ng
Liyan Xue
Wenjing Yang
Liming Shi
Hui Wang
Lvhua Wang
Yin Li
author_facet Ruixiang Zhang
Zhen Wang
Xiaozheng Kang
Xin Wang
Bo Zhang
Hoi-loi Ng
Liyan Xue
Wenjing Yang
Liming Shi
Hui Wang
Lvhua Wang
Yin Li
author_sort Ruixiang Zhang
collection DOAJ
description Esophageal cancer (EC) is particularly common in China. With the continuing progress of multi-disciplinary therapy including early screening, minimally invasive techniques, radiotherapy and chemotherapy, the 5-year survival of EC has been improved in China. However, there are considerable disparities in the diagnosis and treatment quality among different regions. The Esophageal Cancer Expert Committee of the National Cancer Quality Control Center (NCQCC) considers a set of authoritative quality control standards as an opportunity to eliminate the disparities and improve the overall survival and quality of life of EC. To further promote the quality control for standardized diagnosis and treatment of EC, the National Cancer Center commissioned the Esophageal Cancer Quality Control Expert Committee to draft and formulate the Chinese Quality Control Indices for Standardized Diagnosis and Treatment of Esophageal Cancer (2022 edition). The Indices includes 21 items that cover all key areas in the diagnosis and treatment of esophageal cancer, such as medical oncology, radiation oncology, endoscopy, and pathology.
first_indexed 2024-03-11T21:24:09Z
format Article
id doaj.art-aa8aea2ca23e4c619708a27defec5186
institution Directory Open Access Journal
issn 2667-0054
language English
last_indexed 2024-03-11T21:24:09Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Journal of the National Cancer Center
spelling doaj.art-aa8aea2ca23e4c619708a27defec51862023-09-28T05:26:52ZengElsevierJournal of the National Cancer Center2667-00542023-09-0133167174Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)Ruixiang Zhang0Zhen Wang1Xiaozheng Kang2Xin Wang3Bo Zhang4Hoi-loi Ng5Liyan Xue6Wenjing Yang7Liming Shi8Hui Wang9Lvhua Wang10Yin Li11Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Radiotherapy, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaCancer Diagnosis and Treatment Quality Control Office, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaCancer Diagnosis and Treatment Quality Control Office, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaCancer Diagnosis and Treatment Quality Control Office, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Radiotherapy, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Corresponding authors.Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Corresponding authors.Esophageal cancer (EC) is particularly common in China. With the continuing progress of multi-disciplinary therapy including early screening, minimally invasive techniques, radiotherapy and chemotherapy, the 5-year survival of EC has been improved in China. However, there are considerable disparities in the diagnosis and treatment quality among different regions. The Esophageal Cancer Expert Committee of the National Cancer Quality Control Center (NCQCC) considers a set of authoritative quality control standards as an opportunity to eliminate the disparities and improve the overall survival and quality of life of EC. To further promote the quality control for standardized diagnosis and treatment of EC, the National Cancer Center commissioned the Esophageal Cancer Quality Control Expert Committee to draft and formulate the Chinese Quality Control Indices for Standardized Diagnosis and Treatment of Esophageal Cancer (2022 edition). The Indices includes 21 items that cover all key areas in the diagnosis and treatment of esophageal cancer, such as medical oncology, radiation oncology, endoscopy, and pathology.http://www.sciencedirect.com/science/article/pii/S2667005423000455Esophageal cancerStandardized diagnosis and treatmentQuality control index
spellingShingle Ruixiang Zhang
Zhen Wang
Xiaozheng Kang
Xin Wang
Bo Zhang
Hoi-loi Ng
Liyan Xue
Wenjing Yang
Liming Shi
Hui Wang
Lvhua Wang
Yin Li
Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
Journal of the National Cancer Center
Esophageal cancer
Standardized diagnosis and treatment
Quality control index
title Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
title_full Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
title_fullStr Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
title_full_unstemmed Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
title_short Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
title_sort quality control indices for standardized diagnosis and treatment of esophageal cancer in china 2022 edition
topic Esophageal cancer
Standardized diagnosis and treatment
Quality control index
url http://www.sciencedirect.com/science/article/pii/S2667005423000455
work_keys_str_mv AT ruixiangzhang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT zhenwang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT xiaozhengkang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT xinwang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT bozhang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT hoiloing qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT liyanxue qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT wenjingyang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT limingshi qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT huiwang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT lvhuawang qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition
AT yinli qualitycontrolindicesforstandardizeddiagnosisandtreatmentofesophagealcancerinchina2022edition